<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Veliparib (ABT-888) increases NAD+ — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Veliparib (ABT-888)</strong>
  <span class="pred">&mdash;increases&rarr;</span>
  <strong>NAD+</strong>
</div>
<div class="entity-id">CHEBI:62782 &nbsp;&middot;&nbsp; HMDB:HMDB0000902</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 249.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 25 citations: <strong>249.00</strong><br><span style="color:#888">11&times; extends (+132.00) &middot; 11&times; supports (+110.00) &middot; 1&times; contradicts (-5.00) &middot; 2&times; applies (+12.00)</span><br>Neighbourhood: 255.42</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1007/s11306-015-0831-6">10.1007/s11306-015-0831-6</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS177">MTBLS177</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 25 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>11</span><span class="cite-subtotal">&middot; +110.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — increases → serine</span><span class="cite-claim-weight">+10.00</span><a href="../claim/be1ecb14df9e9f05.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — causes → metabolic changes in breast cancer cells</span><span class="cite-claim-weight">+10.00</span><a href="../claim/8a234dddbd66cd81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — correlates_with → radiation metabolic response in HCC1937 (BRCA-mutant) cells</span><span class="cite-claim-weight">+10.00</span><a href="../claim/58b41dc847c7d20b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycerophosphocholine — is_biomarker_for → hPSC-derived cardiomyocyte maturation</span><span class="cite-claim-weight">+10.00</span><a href="../claim/5e9fa87724acaaf5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycerophosphocholine:phosphocholine ratio — is_biomarker_for → hPSC-derived cardiomyocyte maturation</span><span class="cite-claim-weight">+10.00</span><a href="../claim/d57dc4f4ed4c10f5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">glycerophosphocholine — increases → hPSC-derived cardiomyocyte maturation</span><span class="cite-claim-weight">+10.00</span><a href="../claim/54e91a4f5c39fb5a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">pantothenate and Coenzyme A metabolism — increases → hPSC-derived cardiomyocyte maturation</span><span class="cite-claim-weight">+10.00</span><a href="../claim/83a6652034954cc6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">fatty acid oxidation — increases → hPSC-derived cardiomyocyte maturation</span><span class="cite-claim-weight">+10.00</span><a href="../claim/c2307b9a68d53e67.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 overexpression (over-fragmented mitochondria) — increases → lactate</span><span class="cite-claim-weight">+10.00</span><a href="../claim/f9d37ac88c24db97.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 overexpression (over-fragmented mitochondria) — decreases → citrate</span><span class="cite-claim-weight">+10.00</span><a href="../claim/39a502d37c92cada.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">aberrant mitochondrial dynamics — causes → age-related disease pathologies</span><span class="cite-claim-weight">+10.00</span><a href="../claim/a3c080d96cb238b5.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:9px"></span><span>1</span><span class="cite-subtotal">&middot; -5.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">metabolic profile — distinguishes → breast cancer subtypes</span><span class="cite-claim-weight">-5.00</span><a href="../claim/3876734fb5aa3f53.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>11</span><span class="cite-subtotal">&middot; +132.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — increases → glycine</span><span class="cite-claim-weight">+12.00</span><a href="../claim/d424300b34f00439.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — increases → threonine</span><span class="cite-claim-weight">+12.00</span><a href="../claim/eabd8659a1c2f7de.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — increases → taurine</span><span class="cite-claim-weight">+12.00</span><a href="../claim/6f503a27b0bc85c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Veliparib — increases → hypotaurine</span><span class="cite-claim-weight">+12.00</span><a href="../claim/848c3bcf43b46e4d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">radiation — causes → metabolic changes in breast cancer cells</span><span class="cite-claim-weight">+12.00</span><a href="../claim/859bc6045a939792.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">phospholipid metabolism — increases → hPSC-derived cardiomyocyte maturation</span><span class="cite-claim-weight">+12.00</span><a href="../claim/6b104f00e7c3f321.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 mutation (over-fused mitochondria) — increases → succinate</span><span class="cite-claim-weight">+12.00</span><a href="../claim/7bf32f8bcc01af2a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 mutation (over-fused mitochondria) — increases → fumarate</span><span class="cite-claim-weight">+12.00</span><a href="../claim/edf589a7722a24eb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 mutation (over-fused mitochondria) — increases → malate</span><span class="cite-claim-weight">+12.00</span><a href="../claim/f3c0ecc11e6b611d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 mutation (over-fused mitochondria) — increases → citrate</span><span class="cite-claim-weight">+12.00</span><a href="../claim/eb10487ced858f66.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 overexpression (over-fragmented mitochondria) — correlates_with → glycolysis dysregulation</span><span class="cite-claim-weight">+12.00</span><a href="../claim/b1ab46b31b4e1b36.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:18px"></span><span>2</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 overexpression (over-fragmented mitochondria) — decreases → succinate</span><span class="cite-claim-weight">+6.00</span><a href="../claim/36c738bd77b7a7f8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Tmem135 mutation (over-fused mitochondria) — correlates_with → TCA cycle dysregulation</span><span class="cite-claim-weight">+6.00</span><a href="../claim/1f756af85bf6642a.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>a030827dc26ca741</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:62782">CHEBI:62782</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000902">HMDB:HMDB0000902</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
